Literature DB >> 8923048

Penetration of ampicillin and sulbactam into human epididymis and testis.

T Klotz1, M Braun, A Wildfeuer, U Engelmann.   

Abstract

Urologic refertilization microsurgery such as vaso-vasostomy or vaso-epididymostomy benefits from perioperative antibiotic prophylaxis. The ability of ampicillin and sulbactam to penetrate sufficiently into mixed epididymis or testis tissue was investigated in nine patients (bodyweights ranged from 58 kg to 92 kg, mean 77.3 kg) undergoing orchiectomy for testicular cancer or advanced prostatic cancer. Each patient received a single infusion of 3 g ampicillin/sulbactam (ratio 2:1) preoperatively for antibiotic prophylaxis. The concentrations of both components were determined in serum and in epididymis/testis tissue samples taken 30 min to 65 min after infusion. Ampicillin was determined by bioassay and sulbactam was determined by gas chromatography/ mass spectrometry. Mean tissue concentrations of ampicillin were 38.5 +/- 15.9 mg/kg. Mean tissue concentrations of sulbactam at the same time were 19.8 +/- 5.2 mg/kg. Comparison of the tissue/serum ratios for both agents showed no significant difference. These values indicate that both compounds achieve high concentrations in the scrotal organs. The concentrations exceed the MIC (minimal inhibitory concentration) values of important bacterial pathogens such as Staphylococcus aureus involved in postoperative wound infections. The combination of ampicillin and sulbactam may be effective for perioperative prophylaxis in reconstructive scrotal urologic surgery.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923048     DOI: 10.1007/bf01716082

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  11 in total

1.  In vitro activity of sulbactam plus ampicillin against hospital isolates of coagulase-negative staphylococci and Acinetobacter species.

Authors:  U Frank; F D Daschner
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

2.  CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization.

Authors:  A R English; J A Retsema; A E Girard; J E Lynch; W E Barth
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

Review 3.  [Microsurgical techniques in urology].

Authors:  J U Schwarzer; U Pickl; R Hofmann; W Kropp; R Hartung
Journal:  Urologe A       Date:  1994-01       Impact factor: 0.639

4.  Concentrations of ampicillin and sulbactam in serum and in various compartments of the respiratory tract of patients.

Authors:  A Wildfeuer; K H Rühle; P L Bölcskei; M Springsklee
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553

5.  Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.

Authors:  J A Retsema; A R English; A Girard; J E Lynch; M Anderson; L Brennan; C Cimochowski; J Faiella; W Norcia; P Sawyer
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

6.  Concentrations of sulbactam/ampicillin in serum and lung tissue.

Authors:  U Frank; E Schmidt-Eisenlohr; A Joos-Württemberger; J Hasse; F Daschner
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

7.  Pharmacokinetics of ampicillin and sulbactam in patients undergoing heart surgery.

Authors:  A Wildfeuer; V Müller; M Springsklee; H G Sonntag
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

8.  Pharmacokinetics of sulbactam and ampicillin intravenously applied in combination to healthy volunteers and patients. Determination of the ratio of the two drugs in serum and in various tissues.

Authors:  A Wildfeuer; U Schwiersch; K Engel; E von Castell; A Schilling; J Potempa; H Lenders
Journal:  Arzneimittelforschung       Date:  1988-11

9.  Pharmacokinetics of sulbactam in humans.

Authors:  G Foulds; J P Stankewich; D C Marshall; M M O'Brien; S L Hayes; D J Weidler; F G McMahon
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

Review 10.  [Current trends in clinical urology].

Authors:  T Klotz; R Vorreuther; U Engelmann
Journal:  Zentralbl Chir       Date:  1995       Impact factor: 0.942

View more
  2 in total

1.  Penetration of a single infusion of ampicillin and sulbactam into prostatic tissue during transurethral prostatectomy.

Authors:  T Klotz; M Braun; A Bin Saleh; M Orlovski; U Engelmann
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

Review 2.  Epididymo-orchitis caused by enteric organisms in men > 35 years old: beyond fluoroquinolones.

Authors:  Laura Ryan; Padraig Daly; Ivor Cullen; Maeve Doyle
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-02-15       Impact factor: 3.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.